Studying Physician Knowledge, Attitudes, and Practices Regarding the Herpes Zoster Vaccine to Address Perceived Barriers to Vaccination
- 1 July 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Cornea
- Vol. 32 (7) , 976-981
Abstract
Purpose: To increase usage of the herpes zoster (HZ) vaccine at an academic medical center by studying physicians' knowledge, attitudes, practices, and perceived barriers and analyze the findings by practice setting. Methods: A cross-sectional Internet-based survey administered to all 266 general internal medicine physicians in 4 clinical settings at an academic medical center between October 6 and December 12, 2011. Outcomes measures included knowledge questions regarding the disease and vaccine recommendations, Likert-type items about physician attitudes and practices, and questions about barriers and proposed interventions to improve utilization. Results: Response rate was 33.5% (89 of 266). Responders did not answer all questions. Only 66% (42 of 64) responded that HZ vaccination was an important clinical priority, and 48% (38 of 79) reported that less than 10% of their patients received the HZ vaccine. 95% responded that the influenza (61 of 64) and 92% that the pneumococcal (59 of 64) vaccines were important. Approximately 53% (42 of 79) and 51% (40 of 78) reported that more than 75% of their patients received these vaccines, respectively. Top barrier to vaccination was cost to patients (51 of 66; 77%). Lack of awareness of national recommendations (46 of 65, 71%) varied by setting. Physicians' preferred interventions included nurse-initiated prompting about vaccination (36 of 75, 48%) and chart reminders (34 of 74, 46%). Conclusions: Not only increased knowledge but also a change in attitudes and practice are needed to enhance implementation of national recommendations. To improve use of this vaccine, physicians including ophthalmologists need to recommend it more strongly.Keywords
This publication has 20 references indexed in Scilit:
- Practice Patterns and Opinions in the Management of Recurrent or Chronic Herpes Zoster OphthalmicusCornea, 2012
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 YearsClinical Infectious Diseases, 2012
- Primary care physician perspectives on providing adult vaccinesVaccine, 2011
- Herpes Zoster Vaccination Among Adults Aged 60 Years and Older, in the U.S., 2008American Journal of Preventive Medicine, 2011
- Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster DiseaseJAMA, 2011
- Barriers to the Use of Herpes Zoster VaccineAnnals of Internal Medicine, 2010
- Increasing Incidence of Herpes Zoster among VeteransClinical Infectious Diseases, 2010
- Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderlyVaccine, 2009
- A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine IntroductionMayo Clinic Proceedings, 2007
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005